Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tal Kafri

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|February 19, 2004
Gene delivery by lentivirus vectors an overviewTal Kafri
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 27, 2004
A single-LTR HIV-1 vector optimized for functional genomics applicationsHong Ma, Tal Kafri
Current HIV Research|March 31, 2004
HIV-1 vectors: fulfillment of expectations, further advancements, and still a way to goAdam S Cockrell, Tal Kafri
Molecular Biotechnology|September 18, 2007
Gene delivery by lentivirus vectorsAdam S Cockrell, Tal Kafri
Bioinformatics (Oxford, England)|February 20, 2026
PETScan: Score-Based Genome- Wide Association Analysis of RNA-Seq and ATAC-Seq DataYajing Hao, Tal Kafri, Fei Zou
Journal of Neurochemistry|August 23, 2006
Silencing urokinase in the ventral tegmental area in vivo induces changes in cocaine-induced hyperlocomotionAmine Bahi, Frederic Boyer, Tal Kafri, et al.
Gene|January 16, 2003
Methylation of HoxA5 and HoxB5 and its relevance to expression during mouse developmentAlon Y Hershko, Tal Kafri, Abraham Fainsod, et al.
The European Journal of Neuroscience|April 7, 2004
CD81-induced behavioural changes during chronic cocaine administration: in vivo gene delivery with regulatable lentivirusAmine Bahi, Frederic Boyer, Tal Kafri, et al.
The European Journal of Neuroscience|December 22, 2004
In vivo gene delivery of urokinase-type plasminogen activator with regulatable lentivirus induces behavioural changes in chronic cocaine administrationAmine Bahi, Frederic Boyer, Christèle Gumy, et al.
Molecular Therapy. Methods & Clinical Development|August 1, 2015
Generation of a stable packaging cell line producing high-titer PPT-deleted integration-deficient lentiviral vectorsPeirong Hu, Yedda Li, Mark S Sands, et al.
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Methods in Molecular Biology (Clifton, N.J.)|February 19, 2004
Gene delivery by lentivirus vectors an overviewTal Kafri
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 27, 2004
A single-LTR HIV-1 vector optimized for functional genomics applicationsHong Ma, Tal Kafri
Current HIV Research|March 31, 2004
HIV-1 vectors: fulfillment of expectations, further advancements, and still a way to goAdam S Cockrell, Tal Kafri
Molecular Biotechnology|September 18, 2007
Gene delivery by lentivirus vectorsAdam S Cockrell, Tal Kafri
Bioinformatics (Oxford, England)|February 20, 2026
PETScan: Score-Based Genome- Wide Association Analysis of RNA-Seq and ATAC-Seq DataYajing Hao, Tal Kafri, Fei Zou
Journal of Neurochemistry|August 23, 2006
Silencing urokinase in the ventral tegmental area in vivo induces changes in cocaine-induced hyperlocomotionAmine Bahi, Frederic Boyer, Tal Kafri, et al.
Gene|January 16, 2003
Methylation of HoxA5 and HoxB5 and its relevance to expression during mouse developmentAlon Y Hershko, Tal Kafri, Abraham Fainsod, et al.
The European Journal of Neuroscience|April 7, 2004
CD81-induced behavioural changes during chronic cocaine administration: in vivo gene delivery with regulatable lentivirusAmine Bahi, Frederic Boyer, Tal Kafri, et al.
The European Journal of Neuroscience|December 22, 2004
In vivo gene delivery of urokinase-type plasminogen activator with regulatable lentivirus induces behavioural changes in chronic cocaine administrationAmine Bahi, Frederic Boyer, Christèle Gumy, et al.
Molecular Therapy. Methods & Clinical Development|August 1, 2015
Generation of a stable packaging cell line producing high-titer PPT-deleted integration-deficient lentiviral vectorsPeirong Hu, Yedda Li, Mark S Sands, et al.
Pageof 6